Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged.

Infection and Immunity
R BergerM Just

Abstract

Humoral antibodies and specific cellular immune reactions (proliferative immune response in the lymphocyte transformation test) to varicella-zoster virus antigen were measured in children, young adults, and elderly people. In children and young adults, the humoral varicella-zoster-specific antibodies and the virus-specific cellular immune response generally coincided. In the over-60 age group, however, a discrepancy was often observed between these parameters. Ninety percent of the elderly subjects showed humoral antibodies, but only 64% still had a measurable varicella-zoster-specific immune response. There was no correlation between the magnitude of the virus antigen-specific immune response and the mitogen-induced lymphoproliferative response (phytohemagglutinin stimulation). One in three elderly people, therefore, showed no cellular immune response to the varicella-zoster virus antigen, and this person could probably be regarded as a potential herpes zoster patient.

References

Dec 1, 1977·The Journal of Infectious Diseases·T R CateV Knight
Aug 1, 1979·The Journal of Infectious Diseases·S R Preblud, L J D'Angelo
Nov 17, 1978·Medical Microbiology and Immunology·R JenningsC W Potter
Nov 1, 1976·Clinical Immunology and Immunopathology·M M Kay, T Makinodan
Oct 1, 1970·The American Journal of Medicine·L H Miller, P A Brunell
Dec 1, 1974·The Journal of Infectious Diseases·V WilliamsP A Brunell
Nov 1, 1973·Clinical Immunology and Immunopathology·M A PellegrinoR A Reisfeld

❮ Previous
Next ❯

Citations

Nov 1, 1984·Journal of the American Geriatrics Society·J P Harnisch
Dec 1, 1983·Journal of the American Geriatrics Society·J M Felser, M J Raff
Aug 26, 1998·Journal of the American Geriatrics Society·K SchmaderC F Pieper
Feb 22, 2003·Surgical Infections·D E Fry
Oct 30, 2003·Viral Immunology·Donald H GildenRavi Mahalingam
Jan 18, 2005·Clinical Microbiology Reviews·Sophie Hambleton, Anne A Gershon
Oct 5, 2006·Photochemistry and Photobiology·Mary Norval
Oct 29, 2010·Journal of Medical Virology·Won Suk ChoiHee Jin Cheong
Jun 20, 2014·Arthritis & Rheumatology·Kevin L WinthropRichard Riese
Dec 2, 2015·Geriatric Orthopaedic Surgery & Rehabilitation·Alasdair G SutherlandJanet Liversidge
Nov 1, 1990·Journal of the American Geriatrics Society·K SchmaderH J Cohen
Feb 1, 1996·The Pediatric Infectious Disease Journal·S A Plotkin, M A Fletcher
Oct 1, 1994·Clinical and Experimental Immunology·Y ZhangA R Hayward
Jan 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M J Levin
Sep 3, 2004·Nature Reviews. Immunology·Arne N AkbarMike Salmon
Jun 18, 2005·Reviews in Medical Virology·P D Griffiths
May 3, 2008·The Journal of Infectious Diseases·Michael N OxmanUNKNOWN Shingles Prevention Study Group
Mar 4, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·K A GiehlC Berking
Apr 19, 2008·The Journal of Infectious Diseases·M J LevinUNKNOWN Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators
Mar 30, 2007·The New England Journal of Medicine·David W Kimberlin, Richard J Whitley
Mar 30, 2016·Biogerontology·James E Turner
Jan 1, 1989·Critical Reviews in Microbiology·S DarougarR M Woodland
Aug 1, 1996·Immunological Reviews·I Steiner
Oct 1, 1996·Pain·R H Dworkin, R K Portenoy
Jun 3, 2005·The New England Journal of Medicine·M N OxmanUNKNOWN Shingles Prevention Study Group
Aug 17, 2004·Journal of Korean Medical Science·Hyun-Ho Park, Mu-Hyoung Lee
Dec 12, 2012·Epidemiology and Infection·Y OkunoUNKNOWN Shozu Herpes Zoster (SHEZ) Study Group
Dec 1, 1987·Journal of the American Geriatrics Society·M W Rytel
Jun 1, 1992·Epidemiology and Infection·G P Garnett, B T Grenfell
Jun 1, 1992·Journal of Medical Virology·B D SchoubB Miller
Jul 10, 1999·Immunological Reviews·A Abendroth, A Arvin
Aug 25, 2007·Epidemiology and Infection·A A Gershon
Jun 23, 2006·Reviews in Medical Virology·Mark Quinlivan, Judith Breuer
Feb 2, 2010·Expert Opinion on Biological Therapy·C Beau WillisonStephen K Tyring
Sep 1, 1990·Revista Do Instituto De Medicina Tropical De São Paulo·M R VasconcellosM F dos Santos
Mar 1, 1987·Journal of Clinical Immunology·A R Hayward, M Herberger
Apr 3, 2007·Journal of the American Geriatrics Society·Michael R IrwinMichael N Oxman
Nov 25, 2003·Journal of Medical Virology·Satish K MehtaDuane L Pierson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.